Prone-position acquisition of myocardial 123I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using 11C-hydroxyephedrine PET/CT

Annals of Nuclear Medicine

Volumn 28, Issue 8, 2014, Pages 761-769

  Yoshinaga, Keiichiro ^a   Tomiyama, Yuuki ^a   Manabe, Osamu ^a   Kasai, Katsuhiko ^a   Katoh, Chietsugu ^a   Magota, Kenichi ^a   Suzuki, Eriko ^a   Nishijima, Ken ichi ^a   Kuge, Yuji ^a   Ito, Yoichi M ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hydroxyephedrine; MIBG; Prone position; Tomography

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; HYDROXYEPHEDRINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (3 IODOBENZYL)GUANIDINE; CARBON; CATECHOLAMINE; EPHEDRINE; RADIOACTIVE IODINE;

ADULT; ARTICLE; BODY POSTURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; IMAGE RECONSTRUCTION; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MALE; MYOCARDIAL PERFUSION IMAGING; NORMAL HUMAN; PET-CT SCANNER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; SUPINE POSITION; BLOOD; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; HEART; HEART MUSCLE; HEMODYNAMICS; LIVER; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADULT; BODY WEIGHT; CARBON ISOTOPES; CATECHOLAMINES; EPHEDRINE; HEALTHY VOLUNTEERS; HEART; HEMODYNAMICS; HUMANS; IODINE RADIOISOTOPES; LIVER; MALE; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PRONE POSITION; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84919839120     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-014-0868-z     Document Type: Article

References (31)

1. Carrio I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3(1):92–100.
2. Travin MI. Cardiac autonomic imaging with SPECT tracers. J Nucl Cardiol. 2013;20(1):128–43 (quiz 46).
3. Yoshinaga K, Chow BJ, DeKemp RA, Thorn S, Ruddy TD, Davies RA, et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des. 2005;11(7):903–32.
4. Zipes DP. Sympathetic stimulation and arrhythmias. N Engl J Med. 1991;325(9):656–7.
5. Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging. 2012;39(1):113–9.
6. Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol. 2011;18(1):135–43.
7. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55(24):2769–77.
8. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55(20):2212–21.
9. Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol. 1998;5(6):579–90.
10. Guidelines for clinical use of cardiac nuclear medicine (JCS 2010)—digest version. Circ J. 2012;76(3):761–7.
11. Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Improved quantification in 123I cardiac SPECT imaging with deconvolution of septal penetration. Nucl Med Commun. 2006;27(7):551–8.
12. Verberne HJ, Somsen GA, Povinec P, van Eck-Smit BL, Jacobson AF. Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout. Eur J Nucl Med Mol Imaging. 2009;36(8):1322–8.
13. Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med. 1995;36(6):969–74.
14. Ji SY, Travin MI. Radionuclide imaging of cardiac autonomic innervation. J Nucl Cardiol. 2010;17(4):655–66.
15. Segall GM, Davis MJ. Prone versus supine thallium myocardial SPECT: a method to decrease artifactual inferior wall defects. J Nucl Med. 1989;30(4):548–55.
16. Nishina H, Slomka PJ, Abidov A, Yoda S, Akincioglu C, Kang X, et al. Combined supine and prone quantitative myocardial perfusion SPECT: method development and clinical validation in patients with no known coronary artery disease. J Nucl Med. 2006;47(1):51–8.
17. Lautamaki R, Tipre D, Bengel FM. Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging. 2007;34(Suppl 1):S74–85.
18. Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990;82(2):457–64.
19. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300(24):1350–8.
20. Mabuchi M, Imamura M, Kubo N, Morita K, Noriyasu K, Tsukamoto T, et al. Sympathetic denervation and reinnervation after the maze procedure. J Nucl Med. 2005;46(7):1089–94.
21. Matsunari I, Aoki H, Nomura Y, Takeda N, Chen WP, Taki J, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging. 2010;3(5):595–603.
22. Hayes SW, De Lorenzo A, Hachamovitch R, Dhar SC, Hsu P, Cohen I, et al. Prognostic implications of combined prone and supine acquisitions in patients with equivocal or abnormal supine myocardial perfusion SPECT. J Nucl Med. 2003;44(10):1633–40.
23. Rosenspire KC, Haka MS, Van Dort ME, Jewett DM, Gildersleeve DL, Schwaiger M, et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med. 1990;31(8):1328–34.
24. Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol. 1993;22(2):368–75.
25. Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol. 2006;13(6):e121–51.
26. Yoshinaga K, Chow BJ, Williams K, Chen L, DeKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48(5):1029–39.
27. Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation. 2000;101(22):2579–85.
28. Shimizu M, Ino H, Yamaguchi M, Terai H, Hayashi K, Nakajima K, et al. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Nucl Med. 2002;43(1):15–20.
29. Chen W, Cao Q, Dilsizian V. Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections. Curr Cardiol Rep. 2011;13(2):132–7.
30. Kiat H, Van Train KF, Friedman JD, Germano G, Silagan G, Wang FP, et al. Quantitative stress-redistribution thallium-201 SPECT using prone imaging: methodologic development and validation. J Nucl Med. 1992;33(8):1509–15.
31. Hendel RC, Berman DS, Cullom SJ, Follansbee W, Heller GV, Kiat H, et al. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation. 1999;99(21):2742–9.